Ipilimumab (MDX-010) in the treatment of non-small cell lung cancer

By Genova Carlo   Rijavec Erika   Barletta Giulia   Sini Claudio   Dal Bello Maria Giovanna   Truini Mauro   Murolo Carmelina   Pronzato Paolo   Grossi Francesco  

Expert Opinion on Biological Therapy, Vol. 12, Iss. 7, 2012-07 ,pp. : 939-948

Informa Healthcare

Access to resources Recommend Favorite

Alemtuzumab: a novel monoclonal antibody

By Keating Michael J   O’Brien Susan   Ferrajoli Alessandra  

Expert Opinion on Biological Therapy, Vol. 1, Iss. 6, 2001-11 ,pp. : 1059-1065

Informa Healthcare

Access to resources Recommend Favorite

Elotuzumab: a novel anti-CS1 monoclonal antibody for the treatment of multiple myeloma

By Lonial Sagar   Kaufman Jonathan   Laubach Jacob   Richardson Paul  

Expert Opinion on Biological Therapy, Vol. 13, Iss. 12, 2013-12 ,pp. : 1731-1740

Informa Healthcare

Access to resources Recommend Favorite

Broadly expressed tumour?associated proteins as targets for cytotoxic T lymphocyte-based cancer immunotherapy

By Bendle Gavin M   Holler Angelika   Downs Anne-Marie   Xue Shao-An   Stauss Hans J  

Expert Opinion on Biological Therapy, Vol. 5, Iss. 9, 2005-09 ,pp. : 1183-1192

Informa Healthcare

Access to resources Recommend Favorite

Tumor Vascular Targeting Using a Tumor-Tissue Endothelium-Specific Monoclonal Antibody as an Effective Strategy for Cancer Chemotherapy

By Makimoto H.   Koizumi K-i.   Tsunoda S-i.   Wakai Y.   Matsui J.   Tsutsumi Y.   Nakagawa S.   Ohizumi I.   Taniguchi K.   Saito H.   Utoguchi N.   Ohsugi Y.   Mayumi T.  

Biochemical and Biophysical Research Communications, Vol. 260, Iss. 2, 1999-07 ,pp. : 346-350

Elsevier

Access to resources Recommend Favorite